Andrew H Karaba Selected Research

Breakthrough Infections

8/2022	Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine-Induced Immunity in Older Adults.
1/2022	Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections.
1/2022	SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.
1/2022	A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.
10/2021	A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew H Karaba Research Topics

Disease

8	COVID-19 10/2022 - 01/2021
7	Infections 01/2022 - 10/2011
5	Breakthrough Infections 08/2022 - 10/2021
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 12/2014
1	Frailty 08/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Herpetic Keratitis 10/2015
1	Eye Infections 01/2013
1	Herpes Simplex 06/2012
1	Neuroblastoma 06/2012

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 10/2022 - 10/2021
3	NectinsIBA 12/2014 - 10/2011
2	Messenger RNA (mRNA)IBA 10/2022 - 08/2022
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2020
2	mRNA VaccinesIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	COVID-19 VaccinesIBA 01/2022 - 01/2022
2	ChemokinesIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2021
2	Member 14 Tumor Necrosis Factor ReceptorsIBA 10/2015 - 10/2011
1	Biological ProductsIBA 08/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	InterferonsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Chemokine CCL8IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	InflammasomesIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 12/2012
1	Antiviral Agents (Antivirals)IBA 06/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 06/2012

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2012